TrialNCT06274515
A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies
- Status
- RECRUITING
- Phase
- PHASE4
- Last update posted
- 09/04/2026
- Start
- 04/02/2024
- Sponsor
- Hoffmann-La Roche
- Specialties
- oncology
Conditions: Breast Cancer
Brief summary
This study will evaluate mechanisms of resistance to anti-breast cancer therapies in tumor and blood samples from participants with human epidermal growth factor receptor (HER2) positive, hormone receptor (HR) positive or triple negative breast cancer.
Protocol documents and results are not hosted here. Verify every detail on ClinicalTrials.gov.